Prostate Cancer UK Professionals
LightNews LightNews
banner
prostateukprofs.bsky.social
Prostate Cancer UK Professionals
@prostateukprofs.bsky.social
290 followers 440 following 280 posts
Here we share news and views from @ProstateCancerUK for our growing professional community who have an interest in prostate disease 🧑‍🔬⤵️
Posts Replies Media Videos
prostateukprofs.bsky.social
Could GALNT7 be a promising therapeutic target for #ProstateCancer?

A team led by Dr Jennifer Munkley @newcastleuni.bsky.social explores the enzyme's role & emerging strategies to inhibit its activity, writing in Expert Opinion on Therapeutic Targets.

Grab a ☕ & read: doi.org/10.1080/1472...
Scientific Review Paper published in Expert Opinion on Therapeutic Targets, titled: Blocking glycan production by targeting GALNT7 for prostate cancer therapy. Written by Peng et al.
January 27, 2026 at 5:15 PM
prostateukprofs.bsky.social
The January edition of Research News is here! Find out about:

🎯 How we measure the success of our funded research
🥼 UK Prostate Cancer Clinical Research Strategy Group
🧪 Research funding opportunities
📖 External workshops

Read here: buff.ly/l43rtlW
Image of researcher working in the lab, with a graphic in the top right corner saying 'Research News, January 2026'.
January 27, 2026 at 12:30 PM
prostateukprofs.bsky.social
Coming soon! 📢

Applications for our Career Acceleration Fellowships open in March. We’re offering up to £350K over 3-4 years to support early career prostate cancer researchers to advance their career and build collaborations.

🚨Find out more here: buff.ly/E2yRcy8
January 26, 2026 at 4:45 PM
prostateukprofs.bsky.social
💊 NHS England expands access to abiraterone for high-risk localised & locally advanced prostate cancer

⏰ Clinicians: REVIEW diagnoses from the last 12 weeks to ensure eligible patients start treatment before they “time out” of eligibility.

More info ➡️ buff.ly/qSao7sk
Three healthcare professionals, one in business attire and two in medical scrubs, are engaged in a discussion over patients' documents.
January 21, 2026 at 12:01 PM
prostateukprofs.bsky.social
Could androgen-regulated amyloid precursor protein processing drive #ProstateCancer development?

A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol.

Grab a ☕ and read: doi.org/10.3390/cimb...
January 20, 2026 at 5:00 PM
prostateukprofs.bsky.social
🗓️ Just 3 months to go until From Ideas to Innovation!

🚄 Book your travel now - tickets are cheaper & more options.

💸 Travel may be covered by your Prostate Cancer UK grant.

🎟️ Travel bursaries available - first come, first served.

More info 👇

prostatecanceruk.org/research/for...
From Ideas to Innovation is a fantastic opportunity to connect with other researchers and share our work in a relaxed, supportive setting. Researcher quote.
January 20, 2026 at 11:36 AM
prostateukprofs.bsky.social
🎉 BREAKING NEWS

Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland.

Stay tuned — we’ll share more on what this means for you and your patients next week.

Read more: buff.ly/jRDKPrv
Breaking news graphic stating 'Abiraterone approved for more men in England' with a note below mentioning '3,000 lives saved in the next five years.'
January 16, 2026 at 6:05 PM
prostateukprofs.bsky.social
Could targeted alpha therapy be an effective treatment for advanced #ProstateCancer?

An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports.

Grab a ☕ & read: doi.org/10.1038/s415...
Scientific Paper Published in Scientific Reports, titled: Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb- AB001. Written by Stenberg et al.
January 13, 2026 at 5:00 PM
prostateukprofs.bsky.social
Take on our step challenge, March the Month, this March. Walk 11,000 steps a day throughout March for the over 11,000 men who die of #ProstateCancer every year.

Sign up now 👉 bit.ly/44HPo01
January 9, 2026 at 4:45 PM
prostateukprofs.bsky.social
⏰Reminder: CRSG proposal deadline approaching

💡Got a new trial idea to improve outcomes for men with prostate cancer?

Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb

🔗https://buff.ly/W0foIBz
January 8, 2026 at 10:21 AM
prostateukprofs.bsky.social
How has #ProstateCancer treatment evolved over the last five years?

Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com.

Grab a ☕ and read: doi.org/10.1016/S014...
January 6, 2026 at 5:13 PM
prostateukprofs.bsky.social
In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries.

Read the report here: buff.ly/uqqAMNU
The image shows five professionally dressed adults standing side by side in an indoor, formal setting, posing for a group photograph at what appears to be an official or advocacy-related event. They are wearing business attire, including suits, blazers, and identification lanyards, some marked “Visitor,” suggesting participation in an organised meeting or conference. Behind them is a vertical banner prominently referencing prostate cancer and an organisation focused on improving outcomes for men affected by the disease, clearly indicating the purpose of the gathering. The wooden-paneled background and composed posture of the group give the scene a formal, institutional tone, while their relaxed expressions convey collaboration, solidarity, and shared commitment to prostate cancer awareness and advocacy. The image shows a group of five adults standing together indoors in a formal, professional setting, posing for a group photograph at what appears to be an advocacy or awareness event. All are dressed in smart business or business-casual attire, including suits, collared shirts, and blazers, and several wear orange lanyards with identification badges, indicating official participation or visitor status. Positioned behind them is a tall banner referencing prostate cancer and an organisation focused on improving outcomes for men affected by the disease, clearly establishing the purpose of the gathering. The background features a large abstract artwork in deep red tones, adding visual contrast to the scene, while the group’s relaxed posture and friendly expressions convey collaboration, shared purpose, and support for prostate cancer awareness and engagement.
December 19, 2025 at 3:00 PM
prostateukprofs.bsky.social
The December edition of Research News is here! Find out about:

🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.

📚 Read it here: buff.ly/kXTXjdx
Professor Johann de Bono and Dr Adam Sharp stand side by side, looking at a computer screen displaying prostate tissue.
December 19, 2025 at 10:30 AM
prostateukprofs.bsky.social
Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer?

Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.

Grab a ☕ & read: doi.org/10.1016/j.is...
Scientific Paper published in iScience, titled: Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer. Written by Westaby et al.
December 16, 2025 at 5:45 PM
prostateukprofs.bsky.social
Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment.

Hear about current approaches, practical considerations developments within this area.

📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom

Register: bit.ly/492iMjT
Webinar advertisement for "Augmented SBRT: Accuracy in Prostate Cancer Treatment" on January 28, 2026, featuring speakers Prof. Piet Oost, Dr. Stefano Arcoangel, and moderator Prof. Duncan McLaren. Includes a QR code for registration, hosted by Micropos Medical, with a dark blue background and light text.
December 15, 2025 at 3:21 PM
prostateukprofs.bsky.social
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.
December 14, 2025 at 7:11 PM
prostateukprofs.bsky.social
🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson.

📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
December 11, 2025 at 4:30 PM
prostateukprofs.bsky.social
Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments.

In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.

📙 Read more: prostatecanceruk.org/research/res...
December 10, 2025 at 5:30 PM
prostateukprofs.bsky.social
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer?

A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.

Grab a ☕ and read: doi.org/10.1038/s414...
December 9, 2025 at 5:01 PM
prostateukprofs.bsky.social
🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.
December 6, 2025 at 1:24 PM
prostateukprofs.bsky.social
Screening takes time but early diagnosis can’t wait.

Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.

Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b
Infographic by Prostate Cancer UK illustrating the current diagnostic pathway for prostate cancer, including steps from PSA blood test, MRI scan, to targeted transperineal biopsy, followed by diagnosis.
December 5, 2025 at 4:15 PM
prostateukprofs.bsky.social
Ready to lead impactful change? Apply now to be a part of our award-winning 18-month flagship programme.

🌟Apply now: bit.ly/46I5Fn9
Group photo of various health professionals in front of a building, everyone is smiling.
December 5, 2025 at 2:02 PM
prostateukprofs.bsky.social
📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression.

🙏We’re grateful to our research community for sharing their insights and experiences.

⬇️ Check out the full agenda.

prostatecanceruk.org/research/for...
I'm excited to take part in this discussion because it offers an inclusive space to openly explore ideas, share challenges and opportunities in research career progression, and work together to drive meaningful change. Dr Uzoamaka Okoli, University College London.
December 5, 2025 at 8:01 AM
prostateukprofs.bsky.social
🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer.

Find out more ➡️ bit.ly/3xSHfYS
Image featuring portraits of Professors Hashim Ahmed and Mark Emberton, co-leads of the TRANSFORM trial. The text discusses their hopes of revolutionising prostate cancer diagnosis and treatment through the trial. Both are dressed professionally, with Ahmed in surgical attire and Emberton in a suit.
December 4, 2025 at 4:15 PM
prostateukprofs.bsky.social
🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer.

Learn more ➡️ bit.ly/4ip3ysp
Image of Dr. Bunmi Olajide, a GP (primary care clinician), wearing glasses and a suit, with a quote about the importance of early detection of prostate cancer to improve treatment outcomes.
December 3, 2025 at 7:01 PM